What is Dianthus Therapeutics's non-cash lease expense?

Dianthus Therapeutics (DNTH) reported non-cash lease expense of $44K in Q1 2026.

How has Dianthus Therapeutics's non-cash lease expense changed year-over-year?

Dianthus Therapeutics's non-cash lease expense decreased by 58.5% year-over-year, from $106K to $44K.

What does non-cash lease expense mean?

Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.

Dianthus Therapeutics DNTH Non-Cash Lease Expense

Non-Cash Lease Expense at other companies

TG TherapeuticsTGTX

$573K+26.5%

Immunovant, Inc.IMVT

$26K+18.2%

BridgeBio PharmaBBIO

$1.47M+47.5%

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's non-cash lease expense?: Dianthus Therapeutics (DNTH) reported non-cash lease expense of $44K in Q1 2026.
How has Dianthus Therapeutics's non-cash lease expense changed year-over-year?: Dianthus Therapeutics's non-cash lease expense decreased by 58.5% year-over-year, from $106K to $44K.
What does non-cash lease expense mean?: Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.